PGRN deficiency reduces GCase function, leading to the accumulation of glucosylceramide, a lipid implicated in Gaucher disease and an enhancer of tau and α-synuclein aggregation, pathological features of AD and PD [95]. Here, MAPT is linked to Parkinson disease.